Reid Waldman, MD

Reid Waldman, MD, is a dermatologist and chief executive officer of Veradermics.

Articles by Reid Waldman, MD

Executive Insights: Extended-Release Oral Minoxidil Shows Optimized Pharmacokinetics and Potential to Enhance Hair Growth

ByChristopher G. Bunick, MD, PhD,Reid Waldman, MD,Kaitlyn Bader, Assistant Managing Editor

March 29th 2026

At AAD 2026, Christopher Bunick, MD, PhD, and Reid Waldman, MD, discuss investigational VDPHL01, extended-release oral minoxidil, for the treatment of women and men with pattern hair loss.

Latest Updated Articles

Executive Insights: Extended-Release Oral Minoxidil Shows Optimized Pharmacokinetics and Potential to Enhance Hair Growth
March 29th 2026

Reid Waldman, MD

Articles by Reid Waldman, MD

Executive Insights: Extended-Release Oral Minoxidil Shows Optimized Pharmacokinetics and Potential to Enhance Hair Growth

Latest Updated Articles

Trending on Dermatology Times

FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years

Digital Twins in Dermatology: Your Patient’s Virtual Double Is Coming

Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show

Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging

Quality of Life in CSU Shaped by More Than Skin Symptoms